Record Information
Version1.0
Creation Date2009-07-05 02:43:46 UTC
Update Date2026-05-14 16:24:31 UTC
Accession NumberCHEM002081
Identification
Common NameBaclofen
ClassSmall Molecule
DescriptionBaclofen is a gamma-amino-butyric acid (GABA) derivative used as a skeletal muscle relaxant. Baclofen stimulates GABA-B receptors leading to decreased frequency and amplitude of muscle spasms. It is especially useful in treating muscle spasticity associated with spinal cord injury. It appears to act primarily at the spinal cord level by inhibiting spinal polysynaptic afferent pathways and, to a lesser extent, monosynaptic afferent pathways.
Contaminant Sources
  • HMDB Contaminants - Urine
  • STOFF IDENT Compounds
  • T3DB toxins
  • ToxCast & Tox21 Chemicals
Contaminant Type
  • Amine
  • Drug
  • GABA Agonist
  • Human Neurotoxin
  • Metabolite
  • Muscle Relaxant
  • Muscle Relaxant, Central
  • Muscle Relaxant, Skeletal
  • Neuromuscular Agent
  • Organic Compound
  • Organochloride
  • Synthetic Compound
Chemical Structure
Thumb
Synonyms
ValueSource
(+-)-BaclofenChEBI
4-Amino-3-(4-chlorophenyl)butyric acidChEBI
BaclofeneChEBI
BaclofenoChEBI
BaclofenumChEBI
beta-(4-Chlorophenyl)gabaChEBI
beta-(Aminomethyl)-4-chlorobenzenepropanoic acidChEBI
beta-(Aminomethyl)-p-chlorohydrocinnamic acidChEBI
beta-(p-Chlorophenyl)-gamma-aminobutyric acidChEBI
DL-4-Amino-3-p-chlorophenylbutanoic acidChEBI
DL-BaclofenChEBI
gamma-Amino-beta-(p-chlorophenyl)butyric acidChEBI
KemstroKegg
LioresalKegg
4-Amino-3-(4-chlorophenyl)butyrateGenerator
b-(4-Chlorophenyl)gabaGenerator
Β-(4-chlorophenyl)gabaGenerator
b-(Aminomethyl)-4-chlorobenzenepropanoateGenerator
b-(Aminomethyl)-4-chlorobenzenepropanoic acidGenerator
beta-(Aminomethyl)-4-chlorobenzenepropanoateGenerator
Β-(aminomethyl)-4-chlorobenzenepropanoateGenerator
Β-(aminomethyl)-4-chlorobenzenepropanoic acidGenerator
b-(Aminomethyl)-p-chlorohydrocinnamateGenerator
b-(Aminomethyl)-p-chlorohydrocinnamic acidGenerator
beta-(Aminomethyl)-p-chlorohydrocinnamateGenerator
Β-(aminomethyl)-p-chlorohydrocinnamateGenerator
Β-(aminomethyl)-p-chlorohydrocinnamic acidGenerator
b-(p-Chlorophenyl)-g-aminobutyrateGenerator
b-(p-Chlorophenyl)-g-aminobutyric acidGenerator
beta-(p-Chlorophenyl)-gamma-aminobutyrateGenerator
Β-(p-chlorophenyl)-γ-aminobutyrateGenerator
Β-(p-chlorophenyl)-γ-aminobutyric acidGenerator
DL-4-Amino-3-p-chlorophenylbutanoateGenerator
g-Amino-b-(p-chlorophenyl)butyrateGenerator
g-Amino-b-(p-chlorophenyl)butyric acidGenerator
gamma-Amino-beta-(p-chlorophenyl)butyrateGenerator
Γ-amino-β-(p-chlorophenyl)butyrateGenerator
Γ-amino-β-(p-chlorophenyl)butyric acidGenerator
ASTA medica brand OF baclofenMeSH, HMDB
Alphapharm brand OF baclofenMeSH, HMDB
Ashbourne brand OF baclofenMeSH, HMDB
Baclofen athena brandMeSH, HMDB
Baclofen irex brandMeSH, HMDB
BaclospasMeSH, HMDB
Chlorophenyl gabaMeSH, HMDB
Ciba geigy brand OF baclofenMeSH, HMDB
Gen baclofenMeSH, HMDB
GenBaclofenMeSH, HMDB
Isis brand OF baclofenMeSH, HMDB
PCP-GABAMeSH, HMDB
AWD, baclofenMeSH, HMDB
Athena brand OF baclofenMeSH, HMDB
AtrofenMeSH, HMDB
Baclofen apotex brandMeSH, HMDB
Baclofen isis brandMeSH, HMDB
Baclofen medtronic brandMeSH, HMDB
Baclofen nu-pharm brandMeSH, HMDB
Baclofen pharmascience brandMeSH, HMDB
NuBacloMeSH, HMDB
PMS-BaclofenMeSH, HMDB
PMSBaclofenMeSH, HMDB
apo BaclofenMeSH, HMDB
ApoBaclofenMeSH, HMDB
Apotex brand OF baclofenMeSH, HMDB
Baclofen awdMeSH, HMDB
Baclofen ciba-geigy brandMeSH, HMDB
Baclofen novartis brandMeSH, HMDB
Baclofène irexMeSH, HMDB
Baclofène-irexMeSH, HMDB
BaclofèneIrexMeSH, HMDB
CIBA-34,647-baMeSH, HMDB
Gen-baclofenMeSH, HMDB
Irex brand OF baclofenMeSH, HMDB
LebicMeSH, HMDB
Nu bacloMeSH, HMDB
Nu-bacloMeSH, HMDB
Nu-pharm brand OF baclofenMeSH, HMDB
PMS BaclofenMeSH, HMDB
apo-BaclofenMeSH, HMDB
Baclofen alphapharm brandMeSH, HMDB
Baclofen ashbourne brandMeSH, HMDB
BaclophenMeSH, HMDB
CIBA34,647baMeSH, HMDB
Ciba-geigy brand OF baclofenMeSH, HMDB
ClofenMeSH, HMDB
GABA, chlorophenylMeSH, HMDB
GenpharmMeSH, HMDB
Medtronic brand OF baclofenMeSH, HMDB
Novartis brand OF baclofenMeSH, HMDB
Nu pharm brand OF baclofenMeSH, HMDB
Pharmascience brand OF baclofenMeSH, HMDB
Chemical FormulaC10H12ClNO2
Average Molecular Mass213.661 g/mol
Monoisotopic Mass213.056 g/mol
CAS Registry Number1134-47-0
IUPAC Name4-amino-3-(4-chlorophenyl)butanoic acid
Traditional Namebaclofen
SMILESNCC(CC(O)=O)C1=CC=C(Cl)C=C1
InChI IdentifierInChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)
InChI KeyKPYSYYIEGFHWSV-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentGamma amino acids and derivatives
Alternative Parents
Substituents
  • Gamma amino acid or derivatives
  • 3-phenylpropanoic-acid
  • Amino fatty acid
  • Chlorobenzene
  • Aralkylamine
  • Halobenzene
  • Aryl chloride
  • Aryl halide
  • Monocyclic benzene moiety
  • Fatty acyl
  • Benzenoid
  • Amino acid
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organohalogen compound
  • Organic nitrogen compound
  • Primary aliphatic amine
  • Organooxygen compound
  • Primary amine
  • Hydrocarbon derivative
  • Amine
  • Carbonyl group
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Organochloride
  • Organonitrogen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Cytoplasm
  • Extracellular
  • Membrane
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
Applications
Biological Roles
Chemical RolesNot Available
Physical Properties
StateSolid
AppearanceBaclofen occurs as white to off-white crystals (7).
Experimental Properties
PropertyValue
Melting Point206-208°C
Boiling PointNot Available
Solubility2090 mg/L
Predicted Properties
PropertyValueSource
Water Solubility0.71 g/LALOGPS
logP-0.82ALOGPS
logP-0.78ChemAxon
logS-2.5ALOGPS
pKa (Strongest Acidic)3.89ChemAxon
pKa (Strongest Basic)9.79ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area63.32 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity54.83 m³·mol⁻¹ChemAxon
Polarizability21.13 ųChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-001i-9600000000-6ae6d753213a9472b32cSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (1 TMS) - 70eV, Positivesplash10-0ff0-9720000000-6949ab5f0b56c63b916aSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (TBDMS_1_2) - 70eV, PositiveNot AvailableSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QTOF , negativesplash10-03dr-0950000000-33d21cbb6740c1f1aee1Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ , positivesplash10-03di-1590000000-8a64733764308ba98f9aSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ , positivesplash10-0f6t-0900000000-6647c58db763b4df68a0Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ , positivesplash10-0udi-0900000000-72d6d878c9c2f29d846aSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ , positivesplash10-014i-1900000000-18f69033596a03ee643aSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ , positivesplash10-014i-1900000000-997473c303f07afcdf4eSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-IT , positivesplash10-0002-0900000000-d1da4625d180fe0af521Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QTOF , positivesplash10-03di-0190000000-bd0fff49defde62ed0faSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QTOF , positivesplash10-0ik9-0790000000-1a50b0b7f24aaaf6a87eSpectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-0ik9-0890000000-3f3794cee3f3ce674c85Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-01ot-0930000000-4c6fbeef09787ebe54c8Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-016s-0900000000-904b104c639269bfe4f1Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-000i-1900000000-62cafb0d9fec846e47b9Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-03xr-0690000000-4dd9b649eccb58c3cef0Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-03xr-0940000000-08d03c01d7cee16a2833Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0ikl-1900000000-69e953c6f51f0939e70cSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0udj-0900000000-cd340e3600f88734f280Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-0udi-0900000000-89fb1deb3a2cc738679cSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-0mmr-1900000000-62e1c901d161ea96465bSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-03xu-0920000000-6858869b9cb96b03630eSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-0gw0-1900000000-3a4e75e8e4356199aa50Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0gx0-9800000000-bf4ef0f5f1c595bcb485Spectrum
MSMass Spectrum (Electron Ionization)splash10-000i-2900000000-963f049a4367a1d5a5f5Spectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
1D NMR1H NMR SpectrumNot AvailableSpectrum
Toxicity Profile
Route of ExposureInhalation (8); ingestion (8); eye contact (8); dermal (8) Rapidly and almost completely absorbed from the GI tract.
Mechanism of ToxicityBaclofen is a direct agonist at GABAB receptors. The precise mechanism of action of Baclofen is not fully known. It is capable of inhibiting both monosynaptic and polysynaptic reflexes at the spinal level, possibly by hyperpolarization of afferent terminals, although actions at supraspinal sites may also occur and contribute to its clinical effect.
Metabolism~ 15% of the dose is metabolized in the liver, primarily by deamination. 70-80% of the dose is excreted unchanged or as metabolites in urine and the remainder is excreted in feces. Oral Baclofen is readily absorbed from the gastrointestinal tract. After oral administration, baclofen appears in the blodd within half an our. It is fairly distributed in most organs and body tissues. After oral administration of baclofen, about 85% is excreted unchanged in the urine and feces and the remainder is oxidatively dearninated in the liver to produce beta-(p-chlorophenyl)-gamma-hydroxybutyric acid as a major metabolite. (9). Route of Elimination: In a study using radiolabeled baclofen, approximately 85% of the dose was excreted unchanged in the urine and feces. Baclofen is excreted primarily by the kidney as unchanged drug; 70 - 80% of a dose appears in the urine as unchanged drug. The remainder is excreted as unchanged drug in the feces or as metabolites in the urine and feces. Half Life: 2.5-4 hours
Toxicity ValuesLD50: 45 mg/kg (Intravenous, Mouse) (1) LD50: 78 mg/kg (Intravenous, Rat) (1)
Lethal DoseNot Available
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Uses/SourcesFor the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.
Minimum Risk LevelNot Available
Health EffectsHealth effects include hypertonia, hyperthermia, formal thought disorder, psychosis, mania, mood disturbances, restlessness, and behavioral disturbances, tachycardia, seizures, tremors, autonomic dysfunction, hyperpyrexia, extreme muscle rigidity resembling neuroleptic malignant syndrome and rebound spasticity (5).
SymptomsLD50=45 mg/kg (male mice, IV); LD50=78 mg/kg (male rat, IV)
TreatmentTreatment may involve "pumping" the stomach, inducing vomiting, administering an antidote, and providing supportive care. (6)
Concentrations
Not Available
DrugBank IDNot Available
HMDB IDNot Available
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkBaclofen
Chemspider ID2197
ChEBI ID2972
PubChem Compound IDNot Available
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis Reference

Wayne Levadoux, Denis Groleau, Michael Trani, Robert Lortie, “Streptomyces microorganism useful for the preparation of®-baclofen from the racemic mixture.” U.S. Patent US5843765, issued April, 1994.

MSDSLink
General References
1. https://www.ncbi.nlm.nih.gov/pubmed/?term=11772961
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=18682277
3. https://www.ncbi.nlm.nih.gov/pubmed/?term=18824012